Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VITTECOQ, Daniel")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 34

  • Page / 2
Export

Selection :

  • and

ACTIVITE ANTICORPS ANTI-MUSCLE LISSE AU COURS D'UNE MALADIE DE WALDENSTROEM: A PROPOS D'UN CASVITTECOQ DANIEL.1980; ; FRA; DA. 1980; 217; 93 P.; 30 CM; BIBL. 223 REF.; TH.: MED./PARIS 6/1980Thesis

Le risque cardiovasculaire au cours des traitements antirétrovirauxCHIRONI, Gilles; SIMON, Alain; VITTECOQ, Daniel et al.MT. Médecine thérapeutique. 2004, Vol 10, Num 2, pp 120-128, issn 1264-6520, 9 p.Article

Reduced reactive hyperemia in HIV-infected patientsMONSUEZ, Jean-Jacques; DUFAUX, Jacques; VITTECOQ, Daniel et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 25, Num 5, pp 434-442, issn 1525-4135Article

La transplantation hépatique chez les patients co-infectés VIH/VHC et VIH/VHB = Liver transplantation for patients infected with both HIV and HCV or hiv and HBVDUCLOS-VALLEE, Jean-Charles; TEICHER, Elina; VITTECOQ, Daniel et al.MS. Médecine sciences. 2007, Vol 23, Num 8-9, pp 723-728, issn 0767-0974, 6 p.Article

Prévention des complications cardiaques au cours de l'infection par le VIH = Prevention of cardiac complications in AIDSMONSUEZ, Jean-Jacquer; ESCAUT, Lélia; VITTECOQ, Daniel et al.Archives des maladies du coeur et des vaisseaux. Pratique. 2003, Num jun, pp 12-14, issn 1261-694X, 3 p., NSConference Paper

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 TrialCOTTE, Laurent; BRAUN, Joséphine; DE TRUCHIS, Pierre et al.Clinical infectious diseases. 2014, Vol 59, Num 12, pp 1768-1776, issn 1058-4838, 9 p.Article

Le voyageur infecté par le VIH : risques infectieux et prévention = The HIV-infected traveler : infectious risks and preventionCOUZIGOU, Carine; TABURET, Anne Marie; VOYER, Catherine et al.La Presse médicale (1983). 2008, Vol 37, Num 3, pp 490-499, issn 0755-4982, 10 p., CAH2Article

Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIHSALMON, Dominique; BANI-SADR, Firouze; SHOAI-TEHRANI, Michka et al.Journal of hepatology. 2012, Vol 56, Num 4, pp 862-868, issn 0168-8278, 7 p.Article

Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 studyTEICHER, Elina; VINCENT, Isabelle; BONHOMME-FAIVRE, Laurence et al.Clinical pharmacokinetics. 2007, Vol 46, Num 11, pp 941-952, issn 0312-5963, 12 p.Article

Hemorheology in asymptomatic HIV-infected patientsMONSUEZ, Jean-Jacques; DUFAUX, Jacques; VITTECOQ, Daniel et al.Clinical hemorheology and microcirculation. 2000, Vol 23, Num 1, pp 59-66, issn 1386-0291Article

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO TrialFAGARD, Catherine; COLIN, Céline; CHENE, Geneviève et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 5, pp 489-493, issn 1525-4135, 5 p.Article

HIV-associated vascular diseases : Structural and functional changes, clinical implicationsMONSUEZ, Jean-Jacques; CHAMIOT, Jean-Christophe; ESCAUT, Lelia et al.International journal of cardiology. 2009, Vol 133, Num 3, pp 293-306, issn 0167-5273, 14 p.Article

Survival and Recurrence of Hepatitis C After Liver Transplantation in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C VirusDUCLOS-VALLEE, Jean-Charles; FERAY, Cyrille; VITTECOQ, Daniel et al.Hepatology (Baltimore, Md.). 2008, Vol 47, Num 2, pp 407-417, issn 0270-9139, 11 p.Article

Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or Wasting syndromeTROUT, Hervé; MENTRE, France; BERGMANN, Jean-Francois et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 538-545, issn 0066-4804, 8 p.Article

Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment eraVITTECOQ, Daniel; ESCAUT, Lelia; CHIRONI, Gilles et al.AIDS (Supplement). 2003, Vol 17, pp S70-S76, issn 1350-2840, SUP1Article

Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 0102-ST405 cloneMIHAILA, Liliana; WYPLOSZ, Benjamin; CLERMONT, Olivier et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 7, pp 1537-1539, issn 0305-7453, 3 p.Article

Cytokines in HIV-associated cardiomyopathyMONSUEZ, Jean-Jacques; ESCAUT, Lelia; TEICHER, Elina et al.International journal of cardiology. 2007, Vol 120, Num 2, pp 150-157, issn 0167-5273, 8 p.Article

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus : a phase II randomised controlled trial. CommentaryCAHN, Pedro; SUED, Omar; HARVEY, Charlotte M et al.Lancet (British edition). 2007, Vol 369, Num 9569, issn 0140-6736, 1235-1236,1261-1269 [11 p.]Article

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients : The Vacciter Study (ANRS 094)TUBIANA, Roland; CARCELAIN, Guislaine; EL HABIB, Raphaelle et al.Vaccine. 2005, Vol 23, Num 34, pp 4292-4301, issn 0264-410X, 10 p.Article

Carotid intima-media thickness in heavily pretreated HIV-infected patientsCHIRONI, Gilles; ESCAUT, Lelia; GARIEPY, Jerome et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 32, Num 5, pp 490-493, issn 1525-4135, 4 p.Article

Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II StudyGATELL, Jose M; KATLAMA, Christine; MEIBOHM, Anne R et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 4, pp 456-463, issn 1525-4135, 8 p.Article

Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window TrialBOULDOUYRE, Marie-Anne; CHARREAU, Isabelle; MOLINA, Jean-Michel et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 5, pp 531-537, issn 1525-4135, 7 p.Article

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patientsDUCLOS-VALLEE, Jean-Charles; VITTECOQ, Daniel; GUETTIER, Catherine et al.Journal of hepatology. 2005, Vol 42, Num 3, pp 341-349, issn 0168-8278, 9 p.Article

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naïve HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyIZZEDINE, Hassane; SEBASTIEN HULOT, Jean; VITTECOQ, Daniel et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 4, pp 743-746, issn 0931-0509, 4 p.Article

Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patientsCHIAPPINI, Franck; TEICHER, Elina; SAFFROY, Raphaël et al.Laboratory investigation. 2004, Vol 84, Num 7, pp 908-914, issn 0023-6837, 7 p.Article

  • Page / 2